Risperidone in the treatment of two very young children with autism

Journal of Child and Adolescent Psychopharmacology

Volumn 9, Issue 4, 1999, Pages 273-276

  Posey, David J ^a,b   Walsh, Kelda H ^a,b   Wilson, Gregory A ^a,b   McDougle, Christopher J ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ARTICLE; AUTISM; CASE REPORT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSKINESIA; HUMAN; LONG QT SYNDROME; MALE; PRESCHOOL CHILD; TACHYCARDIA;

EID: 0033461141     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1999.9.273     Document Type: Article

References (13)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC, American Psychiatric Press, 1994
2. Anderson LT, Campbell M, Adams P, Small AM, Perry R, Shell J: The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. J Autism Dev Disord 19:227-239, 1989
3. Campbell M, Armenteros JL, Malone RP, Adams PB, Eisenberg ZW, Overall JE: Neuroleptic-related dyskinesias in autistic children: A prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry 36:835-843, 1997
4. Feeney DJ, Klykylo W: Risperidone and tardive dyskinesia. J Am Acad Child Adolesc Psychiatry 35:1421-1422, 1996
5. Fisman S, Steele M: Use of risperidone in pervasive developmental disorders: A case series. J Child Adolesc Psychopharmacol 6:177-190, 1996
6. Kumra S, Herion D, Jacobsen LK, Briguglia C, Grothe D: Case study: Risperidone-induced hepatotoxicity in pediatric patients. J Am Acad Child Adolesc Psychiatry 36:701-705, 1997
7. Mandoki M: Risperidone treatment of children and adolescents: Increased risk of extrapyramidal side-effects? J Child Adolesc Psychopharmacol 5:49-67, 1995
8. McDougle CJ, Holmes JP, Bronson MR, Anderson GM, Volkmar FR, Price LH, Cohen DJ: Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study. J Am Acad Child Adolesc Psychiatry 36:685-693, 1997
9. McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH: A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry 55:633-641, 1998
10. Nicholson R, Awad G, Sloman L: An open trial of risperidone in young autistic children. J Am Acad Child Adolesc Psychiatry 37:372-376, 1998
11. Perry R, Campbell M, Adams P, Lynch N, Spencer EK, Curren EL, Overall JE: Long-term efficacy of haloperidol in autistic children: Continuous versus discontinuous drug administration. J Am Acad Child Adolesc Psychiatry 28:87-92, 1989
12. Ravin DS, Levenson JW: Fatal cardiac event following initiation of risperidone therapy. Ann Pharmacother 31:867-870, 1997
13. Schwam JS, Klass E, Alonso C, Perry R: Risperidone and refusal to eat. J Am Acad Child Adolesc Psychiatry 37:572-573, 1998